This follows the initial licence for treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC) in 2020. Following entry into a commercial agreement with Bayer ...

The NHS says that benign prostate enlargement is common in men over ... to Public-Facing Work After Hospitalization for Cancer Treatment Side Effects King Charles Photographed for the First ...

All men at high risk of prostate cancer should be offered checks even if it costs the NHS more to deliver it ... early improves the odds of successful treatment. The Daily Mail is campaigning ...

AstraZeneca and Merck & Co’s Lynparza will be made available to prostate ... NHS in England and Wales for women with advanced, BRCA-positive ovarian cancer who have stopped responding to ...

A groundbreaking procedure is offering new hope for men suffering from benign prostate hyperplasia (BPH), a condition ...

Older men may experience similar symptoms due to prostate enlargement ... with prostate cancer will not require any treatment at all, the NHS states. A person’s treatment may depend on whether ...

Usually, difficulty urinating is likely to be a sign of a common non-cancerous problem such as an enlarged prostate ...